Literature Archives

BACKGROUND: Routine assessment of programmed death-ligand 1 (PD-L1) expression and comprehensive next-generation sequencing (NGS) is recommended to guide treatment selection in patients with non-small cell lung cancer (N…

BACKGROUND: Lung cancer in adolescents and young adults (AYAs) presents distinct features compared to older populations. METHODS: This population-based study utilized GLOBOCAN 2022 data to estimate lung cancer age-standa…

BACKGROUND: Transbronchial lung cryobiopsy (TBLC) has become an established diagnostic modality in interstitial lung disease (ILD). However, current guidelines frequently exclude patients with severely impaired lung func…

Directly impacts EBUS-TBNA decision-making regarding when further surgical or repeat sampling is warranted.

Provides complementary perspective to EBUS negative predictive value considerations.

The Ion robotic bronchoscopy system demonstrated a significantly higher diagnostic yield, shorter procedure and radiation times, and a lower radiation dose compared to the Monarch system.

A structured, multidisciplinary team-guided strategy for selecting endoscopic sampling modalities achieves high diagnostic yield (92%) and molecular testing adequacy for both malignant and benign mediastinal/hilar lymphadenopathy.

A new Pan-African survey reveals a severe interventional pulmonology capacity gap, marked by a lack of dedicated units (49%), heavy reliance on foreign training (84.6%), and equipment shortages despite soaring clinical demand.

While AirWaze software's preprocedural CT-planning component proved accurate and its ultralow-dose cone-beam computed tomography (CBCT) protocol cut radiation by 94%, the system overall fell short of ideal usability (score of 45/100) due to insufficient image fusion and guidance tools.

Bronchosolve, a fully automated, imaging-only tool, outperforms the standard VA model in predicting lung nodule malignancy risk, showing its greatest benefit in accurately reclassifying intermediate-sized (8 to 15 mm) nodules in a nonscreening setting.

Provides valuable comparative data on image guidance modalities for sampling peripheral pulmonary lesions, impacting procedural planning.

Alternative lung volume measurements—including CT scans and helium dilution—can accurately predict eligibility for endobronchial valve placement in severe COPD patients when standard body plethysmography is unavailable.